Latest / Bend News Today | 2 Min News | The Daily News Now!
mRNA Vaccine Shatters Melanoma Recurrence Odds | Bend News
Merck and Moderna just dropped a game-changing update: their personalized mRNA cancer vaccine, paired with Keytruda, slashes melanoma recurrence by 49% and spread risk by 59% in high-risk patients—potentially extending lives. Built from each patient’s tumor DNA, it’s like a custom key to destroy cancer cells—with mostly mild side effects. FDA approval is pending, but experts predict availability as early as 2027—and this tech could soon target other cancers too. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.